Comment on this story

1 Comments on this story



Post comments

Email to a friend




Send email

    Cancer treatment given the green light

    08 Jul 2009

    Mylan is celebrating the approval of its generic prostate cancer drug after the US Food and Drug Administration (FDA) gave the tablets the all clear.

    The Bicalutamide Tablet is the generic version of AstraZeneca's prostate cancer treatment, Casodex, and was approved after an Abbreviated New Drug Application was submitted to the FDA.

    Mylan stated: "Mylan Inc, which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generics and specialty pharmaceutical companies in the world."

    According to the medical services provider IMS Health, the AstraZeneca version of the drug recorded total sales of $322 million (£199 million) in the last 12 months and Mylan confirmed it is going to start shipping the treatment immediately.

    IMS also said that the company has around 118 outstanding applications with the FDA which could be worth $82.8 billion in annual brand sales.

    The FDA has recently approved Mylan's sleeping therapy Temazepam, which is the generic version of Mallinckrodt's Restoril treatment.

    "NULL


    Bookmark and Share

    1 comments on this story

    Frank Cook says:

    09 July 2009 at 06:52 PM

    Thank you for your cogent thoughts on cancer treatment; this is an important topic of conversation, and I found your contributions provocative and insightful.\r\n\r\nThe organization I work for, the Pacific Northwest Foundation, is devoted to researching alternative modes of healing for a variety of illnesses, including cancer. I wanted to share with you a video presentation of a case study we conducted some years ago about an elderly woman with terminal cancer who, through a variety of methods, was able to eliminate her tumors. The link to the presentation is http://pnf.org/html/cancer.html. \r\n\r\nI\'d like to thank you so much for your contribution to the subject of cancer treatment, and hope you will find the case study above helpful in your continued exploration into the subject.